Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | fused N-acetyl glucosamine-1-phosphate uridyltransferase/glucosamine-1-phosphate acetyl transferase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Wolbachia endosymbiont of Brugia malayi | N-acetylglucosamine-1-phosphate uridyltransferase | Get druggable targets OG5_131193 | All targets in OG5_131193 |
Mycobacterium leprae | Probable UDP-N-acetylglucosamine pyrophosphorylase GlmU | Get druggable targets OG5_131193 | All targets in OG5_131193 |
Mycobacterium ulcerans | bifunctional N-acetylglucosamine-1-phosphate uridyltransferase/glucosamine-1-phosphate acetyltransferase | Get druggable targets OG5_131193 | All targets in OG5_131193 |
Mycobacterium tuberculosis | Probable UDP-N-acetylglucosamine pyrophosphorylase GlmU | Get druggable targets OG5_131193 | All targets in OG5_131193 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable UDP-N-acetylglucosamine pyrophosphorylase GlmU | 0.0684 | 1 | 1 |
Loa Loa (eye worm) | carboxyl transferase domain-containing protein | 0.0169 | 0.1952 | 0.5 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.0067 | 0.0357 | 0.1741 |
Mycobacterium ulcerans | hypothetical protein | 0.0125 | 0.1275 | 0.0952 |
Wolbachia endosymbiont of Brugia malayi | N-acetylglucosamine-1-phosphate uridyltransferase | 0.0684 | 1 | 1 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.0067 | 0.0357 | 0.1741 |
Leishmania major | acetyl-CoA carboxylase, putative | 0.0175 | 0.2048 | 1 |
Treponema pallidum | licC protein (licC) | 0.0125 | 0.1275 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0125 | 0.1275 | 0.0952 |
Chlamydia trachomatis | biotin carboxylase | 0.0061 | 0.0261 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0125 | 0.1275 | 0.0952 |
Brugia malayi | Carboxyl transferase domain containing protein | 0.0169 | 0.1952 | 0.5 |
Trypanosoma cruzi | acetyl-CoA carboxylase | 0.0108 | 0.1007 | 1 |
Mycobacterium ulcerans | molybdopterin-guanine dinucleotide biosynthesis protein A | 0.0125 | 0.1275 | 0.0952 |
Mycobacterium ulcerans | hypothetical protein | 0.0125 | 0.1275 | 0.0952 |
Plasmodium falciparum | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.0127 | 0.1293 | 0.5 |
Toxoplasma gondii | eukaryotic initiation factor-2B, gamma subunit, putative | 0.0125 | 0.1275 | 0.5429 |
Echinococcus granulosus | acetyl coenzyme A carboxylase 1 | 0.0175 | 0.2048 | 1 |
Toxoplasma gondii | acetyl-CoA carboxylase ACC1 | 0.0175 | 0.2048 | 1 |
Mycobacterium ulcerans | bifunctional N-acetylglucosamine-1-phosphate uridyltransferase/glucosamine-1-phosphate acetyltransferase | 0.0684 | 1 | 1 |
Plasmodium vivax | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.0127 | 0.1293 | 0.5 |
Trypanosoma brucei | acetyl-CoA carboxylase | 0.0175 | 0.2048 | 1 |
Schistosoma mansoni | acetyl-CoA carboxylase | 0.0175 | 0.2048 | 1 |
Toxoplasma gondii | acetyl-coA carboxylase ACC2 | 0.0175 | 0.2048 | 1 |
Echinococcus multilocularis | acetyl coenzyme A carboxylase 1 | 0.0175 | 0.2048 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 6 | Inhibition of Escherichia coli GlmU acetyltransferase activity assessed as coenzyme A production using acetyl CoA substrate | ChEMBL. | 25544688 |
IC50 (binding) | = 1 uM | Inhibition of Escherichia coli GlmU acetyltransferase activity assessed as coenzyme A production using acetyl CoA substrate | ChEMBL. | 25544688 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.